Showing results (291-300 of 364) with videos related to

Sort By:
Pageof 37
American Journal of Obstetrics and Gynecology|June 26, 2010
Complex atypical hyperplasia of the uterus: characteristics and prediction of underlying carcinoma riskMario M Leitao, Guangming Han, Lisa X Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 13, 2009
IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtypeMartin Köbel, Haodong Xu, Patricia A Bourne, et al.
Gynecologic Oncology|March 2, 2022
Sentinel lymph node biopsy alone compared to systematic lymphadenectomy in patients with uterine carcinosarcomaWilliam A Zammarrelli, Michelle Greenman, Eric Rios-Doria, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 14, 2012
Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinomaRussell Vang, Kala Visvanathan, Amy Gross, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|October 28, 2022
Data Set for Reporting of Uterine Malignant and Potentially Malignant Mesenchymal Tumors: Recommendations From the International Collaboration on Cancer Reporting (ICCR)Marisa R Nucci, Fleur Webster, Sabrina Croce, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2021
Clinicopathologic and Genomic Analysis of TP53-Mutated Endometrial CarcinomasAmir Momeni-Boroujeni, Wissam Dahoud, Chad M Vanderbilt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 27, 2016
Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomasMackenzie Coatham, Xiaodong Li, Anthony N Karnezis, et al.
The American Journal of Surgical Pathology|January 13, 2017
Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular SubgroupLien N Hoang, Mary A Kinloch, Joyce M Leo, et al.
Gynecologic Oncology|July 7, 2023
A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283Roisin E O'Cearbhaill, Austin Miller, Robert A Soslow, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 19, 2015
A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancerLaura Romero-Pérez, Pablo Garcia-Sanz, Alba Mota, et al.
Pageof 37